New Delhi: India introduces 3 new vaccines for combating the COVID-19 in the country. Drug regulator Drugs Controller General of India (DCGI) recently gave nod to Serum Institute of India's vaccine Covovax, Biological E's jab Corbevax and anti-Covid pill Molnupiravir. These vaccines are to be used in emergency situations.
Union Health Minister Mansukh Mandaviya on Tuesday made the official announcement in this regard, This comes a day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax.
The committee had also granted restricted emergency use approval to the drug Molnupiravir. Molnupiravir is used for the treatment of adult patients with COVID-19 and who have a high risk of progression of the virus.
Covid Vaccine की वजह से हो रहे हैं हार्ट अटैक? जानें AIIMS के ...
COVID-19 Vaccines Not Related To The Rise Of Deaths Due To Heart Attack: ICMR-AIIMS Studies ...
Covid Vaccine-Heart Attack Link : क्या कोरोना वैक्सीन से आ रहा है हार्ट ...
COVID-19 Cases In India: 6000 पार हुए कोरोना के एक्टिव केस, Alert पर ...